Tumor ki67 Impact on Survival in Male Breast Cancer Patients: A Systematic Review and Meta-Analysis
Clinical Breast Cancer · 2025
DOI: 10.1016/j.clbc.2025.05.013 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical Breast Cancer, 2025. Verfasst von Stephen Kinsey-Trotman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Surgical Specialties, Adelaide Medical School, University of Adelaide, The Queen Elizabeth Hospital, Woodville South, South Australia, …. Hauptthemen laut MEDLINE: Ki-67 Antigen, Breast Neoplasms, Male, Biomarkers, Tumor. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Government.
Themen: Onkologische Pflege
Abstract (Originalsprache)
PURPOSE: Histological features with prognostic utility for survival in male breast cancer remain elusive. Tumor ki67 expression may provide an early prognostic marker in this disease. This systematic review investigated ki67 prognostication for overall survival in male breast cancer patients. METHODS: Following prospective registration MEDLINE, PUBMED Central and EMBASE databases were searched to identify suitable studies. Studies were considered for meta-analysis when both comparable research methodologies were utilized and survival outcomes were reported for the same threshold value for ki67. RESULTS: A total of fifteen observational type studies were included in the review with 9 meeting inclusion criteria for data extraction. Six studies contributed to a meta-analysis. Two studies demonstrated a statistically-significant difference in survival outcome at a ki67 threshold of 20%, however meta-analysis for ki67 set at 2 thresholds (14% and 20%) did not demonstrate any significant association with overall survival. CONCLUSIONS: This review did not confirm an association between ki67 and overall survival in male breast cancer patients. Further research including the use of artificial intelligence methods and consideration of a higher threshold value are needed to better define Tumor ki67 in this patient group.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Discipline of Surgical Specialties, Adelaide Medical School, University of Adelaide, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia; Robinson Research Institute, University of Adelaide, Adelai…
- Lyell McEwin Hospital, Northern Adelaide Local Health Network, Elizabeth Vale, South Australia, Australia.
- School of Public Health, University of Adelaide, Adelaide, South Australia, Australia.
- SA Pathology, Central Adelaide Local Health Network, Woodville South, South Australia, Australia.
- Discipline of Surgical Specialties, Adelaide Medical School, University of Adelaide, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia; SA Pathology, Central Adelaide Local Health Network, Woodvi…
Förderung
- Australian Government
Zitieren
APA
Kinsey-Trotman, S., Nguyen, A., Edwards, S., Swalling, A., Dasari, P., Walsh, D., & Ingman, W. V. (2025). Tumor ki67 Impact on Survival in Male Breast Cancer Patients: A Systematic Review and Meta-Analysis. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2025.05.013
Vancouver
Kinsey-Trotman S, Nguyen A, Edwards S, Swalling A, Dasari P, Walsh D, et al. Tumor ki67 Impact on Survival in Male Breast Cancer Patients: A Systematic Review and Meta-Analysis. Clinical Breast Cancer. 2025. doi:10.1016/j.clbc.2025.05.013
BibTeX
@article{KinseyTrotman2025,
author = {Kinsey-Trotman, Stephen and Nguyen, Alain and Edwards, Suzanne and Swalling, Adam and Dasari, Pallave and Walsh, David and Ingman, Wendy V},
title = {Tumor ki67 Impact on Survival in Male Breast Cancer Patients: A Systematic Review and Meta-Analysis},
journal = {Clinical Breast Cancer},
year = {2025},
doi = {10.1016/j.clbc.2025.05.013}
}
EUVIMED